NSTM
NovelStem International Corp. focuses on developing and commercialization of diagnostic technology for cancer treatments and the potential to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was founded in 1993 and is headquartered in Boca Raton, Florida.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.00 | $0 | -$138,731 |
| 2025 Q4 | -0.00 | $0 | -$71,072 |
| 2025 Q3 | -0.00 | $0 | $18,410 |
| 2025 Q2 | 0.06 | $0 | -$66,795 |
| 2025 Q1 | -0.00 | $0 | -$43,698 |
| 2024 Q4 | -0.04 | $3,000 | -$39,220 |
| 2024 Q3 | -0.05 | $3,000 | -$62,552 |
| 2024 Q2 | -0.01 | $3,000 | -$97,310 |